
Telepathology Slide Scanner Market Report 2026
Global Outlook – By Product Type (Brightfield Scanners, Fluorescence Scanners, Whole Slide Imaging Scanners), By Technology (Digital Pathology, Virtual Microscopy, Other Technologies), By Application (Disease Diagnosis, Education, Research, Other Applications), By End-User (Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Telepathology Slide Scanner Market Overview
• Telepathology Slide Scanner market size has reached to $1.5 billion in 2025 • Expected to grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 14% • Growth Driver: Rising Prevalence Of Chronic Diseases Fueling The Growth Of The Market Due To Rising An Aging Population • Market Trend: High-Speed Digital Pathology Slide Scanners Enhance Remote Diagnostics And Workflow Efficiency • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Telepathology Slide Scanner Market?
A telepathology slide scanner is a digital imaging device that captures high-resolution images of pathology slides for remote examination and analysis. It converts physical slides into detailed digital formats, enabling efficient sharing and evaluation across locations. A telepathology slide scanner enhances diagnostic accuracy and streamlines workflow, reducing the time required for slide assessment, and supports real-time collaboration and rapid decision-making in pathology. The main product types of telepathology slide scanners are brightfield scanners, fluorescence scanners, whole slide imaging scanners, and others. Brightfield scanners capture high-resolution images of stained tissue slides using transmitted light for routine pathology analysis. The scanner technologies include digital pathology, virtual microscopy, and others used for various applications such as disease diagnosis, education, research, and others, and the key end-users are hospitals, diagnostic laboratories, academic and research institutes, and others.
What Is The Telepathology Slide Scanner Market Size and Share 2026?
The telepathology slide scanner market size has grown rapidly in recent years. It will grow from $1.5 billion in 2025 to $1.72 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to pathologist shortage, increasing cancer diagnostics, laboratory digitalization, need for remote consultation, advances in imaging technology.What Is The Telepathology Slide Scanner Market Growth Forecast?
The telepathology slide scanner market size is expected to see rapid growth in the next few years. It will grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to AI-driven diagnostic accuracy, telepathology adoption growth, global pathology collaboration, workflow automation, precision medicine expansion. Major trends in the forecast period include whole slide digital imaging, remote pathology diagnostics, ai-assisted slide analysis, high-throughput slide scanning, cloud-based pathology workflows.Global Telepathology Slide Scanner Market Segmentation
1) By Product Type: Brightfield Scanners, Fluorescence Scanners, Whole Slide Imaging Scanners 2) By Technology: Digital Pathology, Virtual Microscopy, Other Technologies 3) By Application: Disease Diagnosis, Education, Research, Other Applications 4) By End-User: Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Other End-Users Subsegments: 1) By Brightfield Scanners: Automated Brightfield Scanners, Semi-Automated Brightfield Scanners, Manual Brightfield Scanners 2) By Fluorescence Scanners: Single-Channel Fluorescence Scanners, Multi-Channel Fluorescence Scanners, Confocal Fluorescence Scanners 3) By Whole Slide Imaging Scanners: High-Throughput Whole Slide Imaging Scanners, Medium-Throughput Whole Slide Imaging Scanners, Low-Throughput Whole Slide Imaging ScannersWhat Is The Driver Of The Telepathology Slide Scanner Market?
The rising prevalence of chronic diseases is expected to propel the growth of the telepathology slide scanner market going forward. Chronic diseases refer to long-lasting health conditions such as cardiovascular disease, diabetes, cancer, and respiratory disorders that typically progress slowly and require ongoing medical attention. The prevalence of chronic diseases is surging primarily due to the aging population, as biological aging causes cell damage, weaker immunity, and slower tissue repair, making older adults more susceptible to chronic health conditions. Telepathology slide scanners facilitate quick remote examination of tissue and biopsy samples, aiding early detection and ongoing monitoring of chronic diseases such as cancer while enhancing diagnostic precision, reducing turnaround time, and enabling expert collaboration for improved long-term care. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, 76.4% of US adults, representing about 194 million people, reported having one or more chronic conditions in 2023, highlighting the widespread and growing burden of long-term illnesses across the population. Therefore, the rising prevalence of chronic diseases is driving the growth of the telepathology slide scanner industry.Key Players In The Global Telepathology Slide Scanner Market
Major companies operating in the telepathology slide scanner market are Leica Biosystems, Hamamatsu Photonics K.K., 3DHISTECH Ltd., OptraSCAN Inc., Huron Digital Pathology Inc., Motic Group Co. Ltd., Grundium Ltd., KFBIO Co. Ltd., Excilone SAS, Wuhan Landing Intelligence Medical Co. Ltd., DSS Imagetech Pvt. Ltd., Carl Zeiss AG, Evident Scientific Inc., Keyence Corporation, F. Hoffmann-La Roche AG, Koninklijke Philips N.V., Meyer Instruments Inc., MBF Bioscience LLC, Mindray Bio-Medical Electronics Co. Ltd., VisionTek Systems Ltd.Global Telepathology Slide Scanner Market Trends and Insights
Major companies operating in the telepathology slide scanner market are focusing on developing digital pathology solutions, such as high-speed slide scanners, to accelerate diagnostic workflows and enable seamless remote pathology analysis. A high-speed slide scanner rapidly captures high-resolution images of pathology slides, enabling quick and accurate analysis while supporting remote diagnostics and streamlining workflows for improved efficiency in clinical and research settings. For instance, in September 2024, Vieworks Co., Ltd., a South Korea–based provider of digital imaging and bioimaging solutions, launched the LUCEON 510, a high-speed digital pathology slide scanner, during the European Congress of Pathology (ECP) 2024 held in Italy. The LUCEON 510 marks Vieworks’ entry into digital pathology, featuring a three-camera architecture that captures three differently focused images simultaneously and merges them in real time to produce high-resolution whole slide images. It is designed for efficiency, offering four imaging modes optimized for histopathology and cytology applications, achieving up to 83 slides per hour with a capacity of 510 slides per load.What Are Latest Mergers And Acquisitions In The Telepathology Slide Scanner Market?
In August 2025, Evident Corporation, a Japan-based laboratory equipment and consumables manufacturing company, acquired Pramana Inc. for an undisclosed amount. Through this acquisition, Evident gains Pramana’s automated whole slide imaging systems, versatile scanning and workflow platform, and AI-driven quality control technologies, enhancing its digital and telepathology capabilities while enabling more scalable operations, smoother workflow integration, and improved service. Pramana Inc. is a US-based health technology company specializing in fully autonomous image scanning systems for pathology.Regional Outlook
North America was the largest region in the telepathology slide scanner market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Telepathology Slide Scanner Market?
The telepathology slide scanner market consists of revenues earned by entities by providing services such as high-resolution digital slide scanning, remote pathology consultations, image storage and management, tele-education and training, and maintenance and calibration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The telepathology slide scanner market also includes sales of hybrid scanners, confocal scanners, multiplex scanners, high-throughput scanners, and portable or compact scanners. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Telepathology Slide Scanner Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.72 billion |
| Revenue Forecast In 2035 | $2.91 billion |
| Growth Rate | CAGR of 14.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Technology, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Leica Biosystems, Hamamatsu Photonics K.K., 3DHISTECH Ltd., OptraSCAN Inc., Huron Digital Pathology Inc., Motic Group Co. Ltd., Grundium Ltd., KFBIO Co. Ltd., Excilone SAS, Wuhan Landing Intelligence Medical Co. Ltd., DSS Imagetech Pvt. Ltd., Carl Zeiss AG, Evident Scientific Inc., Keyence Corporation, F. Hoffmann-La Roche AG, Koninklijke Philips N.V., Meyer Instruments Inc., MBF Bioscience LLC, Mindray Bio-Medical Electronics Co. Ltd., VisionTek Systems Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
